ECMO 的演變與 Robert Bartlett 博士(第 1 部分)
Published on
救生 ECMO 療法不斷發展。 收看這個一對一的訪談,美敦力 (Medtronic) 首席醫療官兼心臟外科副總裁 Pieter Kappetein 教授將與世界著名外科醫生、被譽為“ECMO 之父”的羅伯特·巴特利特 (Robert Bartlett) 博士進行交談。 他們討論了 ECMO 自誕生以來的演變,以及推動當今救生 ECMO 變革的主要趨勢和指南。 Bartlett 博士還分享了他對那些有興趣啟動 ECMO 計劃的人的關鍵成功因素的看法。
The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.
DISCLAIMER: The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing. If not approved, please exit this page.
Other News
Cards
-
二尖瓣修復的最新進展和趨勢(第 4 部分)
Published on
在本系列中,美敦力首席醫療官兼心臟外科副總裁 Pieter Kappetein 教授、紐約大學的 Eugene Grossi 博士、普萊諾 Baylor Scott & White 的 Robert L. Smith 博士和華盛頓的 Puja Kachroo 博士 聖路易斯大學醫學院討論二尖瓣患者的治療已經發生和即將發生的變化。 詳細了解 MICS 程序的重要性、設置機器人程序的關鍵步驟以及二尖瓣心臟團隊的重要性。
The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.
Access Now
-
二尖瓣修復的最新進展和趨勢(第 3 部分)
Published on
在本系列中,美敦力首席醫療官兼心臟外科副總裁 Pieter Kappetein 教授、紐約大學的 Eugene Grossi 博士、普萊諾 Baylor Scott & White 的 Robert L. Smith 博士和華盛頓的 Puja Kachroo 博士 聖路易斯大學醫學院討論二尖瓣患者的治療已經發生和即將發生的變化。 詳細了解 MICS 程序的重要性、設置機器人程序的關鍵步驟以及二尖瓣心臟團隊的重要性。
The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.
Access Now
-
二尖瓣修復的最新進展和趨勢(第 2 部分)
Published on
在本系列中,美敦力首席醫療官兼心臟外科副總裁 Pieter Kappetein 教授、紐約大學的 Eugene Grossi 博士、普萊諾 Baylor Scott & White 的 Robert L. Smith 博士和華盛頓的 Puja Kachroo 博士 聖路易斯大學醫學院討論二尖瓣患者的治療已經發生和即將發生的變化。 詳細了解 MICS 程序的重要性、設置機器人程序的關鍵步驟以及二尖瓣心臟團隊的重要性。
The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.
Access Now